logo
Department of Health – Abu Dhabi signs a Memorandum of Understanding with Microsoft to create an AI-powered Population Health Intelligence framework

Department of Health – Abu Dhabi signs a Memorandum of Understanding with Microsoft to create an AI-powered Population Health Intelligence framework

Mid East Info21-04-2025
Abu Dhabi, UAE: Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the emirate, has signed a Memorandum of Understanding (MoU) with Microsoft to co-develop an advanced 'Population Health Intelligence' framework – a world's first true learning health system. Signed at Abu Dhabi Global Health Week (ADGHW), the framework aims to create a true learning health system capable of continuously predicting, preventing, and responding to public health challenges.
The MoU was signed by H.E. Ibrahim Al Jallaf, Executive Director of Digital Health at DoH and Naim Yazbeck, Country General Manager from Microsoft UAE.
Around the world, fragmented data systems and reactive models are failing to meet the rising demands for treating complex chronic conditions. As health systems worldwide focus towards shifting from reactive to predictive models, Abu Dhabi is taking a bold step forward, turning billions of data points into life-changing insights driven by artificial intelligence (AI) and advanced analytics into actionable interventions at the individual and population level.
The 'Population Health Intelligence' framework is built on two interconnected pillars:
Predict: Establish a digital twin of Abu Dhabi that consolidates clinical, behavioural, environmental and demographic data into a unified view, enabling AI to proactively detect and address health anomalies for early investigation.
Prevent and Act: Deploy AI-powered, context-aware recommendations tailored to population, district, and individual levels; simulate the future impact of interventions; and enable coordinated response based on real-time feedback.
In line with its commitment to ensuring the highest standards of data protection, DoH guarantees that all patient data will be handled with the utmost confidentiality and security. This initiative adheres to robust privacy regulations, ensuring that sensitive information is safeguarded against unauthorized access and breaches. By embedding intelligence into every layer of the health system, the framework supports Abu Dhabi's objective to shift from reactive care to proactive healthspan for all.
Commenting on the announcement, H.E. Ibrahim Al Jallaf said: 'Our mission goes beyond delivering healthcare, we are shaping a new era of longevity, where data, prevention, and innovation come together to empower healthier lives. Through advanced technologies, global collaboration, and bold policy thinking, we are building a resilient health ecosystem that anticipates needs, addresses disparities, and unlocks the full potential of every individual. Abu Dhabi is proud to lead the charge in redefining what health systems can achieve when informed by data-led insights, and driven by purpose.'
Through this collaboration, DoH will leverage Microsoft's trusted and secure cloud platforms and AI technologies to span multiple workstreams, including concept and prototype development, value assurance, integration of the framework into Abu Dhabi's existing digital health ecosystem, and knowledge-sharing in the public domain through conferences and global reports.
Commenting on the intent of this partnership, Mr. Yazbeck said: 'This collaboration reflects the transformative potential of artificial intelligence and cloud technologies in solving some of the world's most pressing healthcare challenges. By enabling secure, real-time insights across population-level data, we are partnering with the Department of Health – Abu Dhabi to build the digital foundations of a more predictive, personalised, and resilient healthcare system. Together, we are driving innovation that places data and intelligence at the heart of proactive care.'
The 'Population Health Intelligence' framework will focus on key population health challenges including chronic disease prevention, early detection, and health equity. Reflecting Abu Dhabi's commitment to global impact, DoH will share relevant insights and innovations from this collaboration in the public domain, supporting the development of similar models worldwide.
ADGHW is a major government initiative from DoH and serves as a platform for innovation and collaboration under the theme 'Towards Longevity: Redefining Health and Well-being.' It places a strong emphasis on community-driven health and well-being, with a proactive approach centred around preventive, personalised, and holistic care.
Four core themes guided discussions and initiatives: Longevity and Precision Health; Health System Resilience & Sustainability; Digital Health & AI; and Investment in Life Sciences. By convening diverse stakeholders from around the world, ADGHW is a community without borders that seeks to advance the future of health and well-being.
About Abu Dhabi Global Health Week:
Abu Dhabi Global Health Week (ADGHW) is a major government-led initiative by the Department of Health – Abu Dhabi (DoH). It drives transformative innovation and collaboration under the theme 'Towards Longevity: Redefining Health and Well-being'. ADGHW serves as a year-round 'always-on' platform with a proactive approach centred around preventive, personalised, and holistic care. Held with and for the world, ADGHW is a platform for open, inclusive exchange, and joint action.
ADGHW welcomes entrepreneurs, policymakers, researchers, innovators, and investors to transform ideas into action, and collaborate around topics like advancing precision care and building a resilient technology-driven ecosystem. ADGHW 2025 proudly collaborates with key strategic partners, including Foundation Partner, M42 and Global Health and Longevity Champion, PureHealth. Additional exhibitors and sponsors include Burjeel, GSK, Johnson & Johnson, Lilly, Microsoft, Novo Nordisk, Viatris, Novartis, Roche, Cleveland Clinic Abu Dhabi, Deloitte, Gilead, Juvenescence, NYU Abu Dhabi and Pfizer, united in their commitment to advancing the future of healthcare and life sciences.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Abu Dhabi Startup Ovasave Raises $1.2M to Expand Fertility Platform
Abu Dhabi Startup Ovasave Raises $1.2M to Expand Fertility Platform

CairoScene

time21-07-2025

  • CairoScene

Abu Dhabi Startup Ovasave Raises $1.2M to Expand Fertility Platform

Founded in 2023, Ovasave focuses on fertility and hormonal health, offering a digital-first service for hormone testing, egg freezing, virtual consultations, and menopause care. Jul 21, 2025 Abu Dhabi-based FemTech startup Ovasave has secured $1.2 million in pre-seed funding to scale its digital health platform across the GCC. The round was led by PlusVC, Annex Investments, and New York's 25 Madison, with additional support from strategic angel investors and family offices in the UAE and Saudi Arabia. Founded in 2023, Ovasave focuses on fertility and hormonal health, offering a digital-first service for hormone testing, egg freezing, virtual consultations, and menopause care. Its platform combines at-home diagnostic tools with personalised care protocols and access to fertility clinics. The company also runs a corporate benefits programme, aimed at helping organisations offer reproductive health services as part of employee wellbeing strategies. "There is a critical need for timely intervention in women's health, particularly around fertility and hormonal health, Torkia Mahloul, Co-founder and CEO of Ovasave said. "This funding marks a crucial step in our mission to disrupt women's health and expand access to fertility and hormonal care across the region. A recent report by FemTech Analytics showed that the FemTech market in the region is projected to reach $3.8 billion by 2031, growing at a CAGR of 15% from 2021 to 2031. The new capital will support Ovasave's regional expansion, the scaling of employer partnerships, and the development of the next version of its mobile app. Upcoming features will include menstrual cycle tracking, symptom monitoring, AI-supported treatment recommendations, and expanded menopause support. Ovasave is registered with the Department of Health – Abu Dhabi and is part of the Hub71 tech ecosystem, aligning its services with national efforts to digitise healthcare and expand access to preventive care.

Gulf's First Robotic Lung Transplant Performed in Abu Dhabi
Gulf's First Robotic Lung Transplant Performed in Abu Dhabi

CairoScene

time11-07-2025

  • CairoScene

Gulf's First Robotic Lung Transplant Performed in Abu Dhabi

Two patients with progressive conditions underwent successful robotic lung transplants at the hospital. Jul 11, 2025 In a historic breakthrough for regional healthcare, Cleveland Clinic Abu Dhabi has become the first medical institution in the Gulf to perform a robotic lung transplant—making it just the fifth centre worldwide to do so. The landmark procedure marks a major advancement in the region's surgical capabilities. Two patients with idiopathic pulmonary fibrosis and secondary pulmonary hypertension—both progressive conditions that severely scar the lungs—underwent successful robotic lung transplants at the hospital. Given the complexity of the cases, which included pulmonary hypertension placing additional strain on the heart and lungs, the surgical team employed Veno-Arterial ECMO (Extracorporeal Membrane Oxygenation). This technique temporarily takes over the function of both the heart and lungs, ensuring patients' safety during the transplant. The surgeries were made possible through the vital contributions of organ donor families, with Cleveland Clinic Abu Dhabi extending its gratitude to the HAYAT National Programme for Organ Donation and Transplantation, the Department of Health – Abu Dhabi, the Ministry of Health and Prevention (MOHAP), and the healthcare teams at donor hospitals. Since the relaunch of its lung transplant programme in 2022, the hospital has performed over 60 lung transplants—more than any other facility in the Gulf.

The Department of Health – Abu Dhabi and Abbott Unite to Manufacture Pharmaceuticals Locally in Abu Dhabi - Middle East Business News and Information
The Department of Health – Abu Dhabi and Abbott Unite to Manufacture Pharmaceuticals Locally in Abu Dhabi - Middle East Business News and Information

Mid East Info

time21-06-2025

  • Mid East Info

The Department of Health – Abu Dhabi and Abbott Unite to Manufacture Pharmaceuticals Locally in Abu Dhabi - Middle East Business News and Information

During BIO International Convention in Boston USA, the Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in Abu Dhabi, and Abbott, the global healthcare leader, entered a landmark partnership to localise manufacturing of pharmaceuticals in Abu Dhabi and advance digital health solutions. Leveraging Abu Dhabi's advanced life sciences infrastructure, this milestone reflects the emirate's proactive preparedness to reduce dependency on imports, strengthen supply chain resilience, and foster a sustainable, self-sufficient healthcare ecosystem. H.E. Dr. Noura Al Ghaithi, Undersecretary of the Department of Health – Abu Dhabi, said: 'Following the recent launch of the Health, Endurance, Longevity and Medicine (HELM) Cluster in Abu Dhabi, the emirate proved to be equipped with a holistic, integrated infrastructure that fosters local manufacturing and R&D, positioning it as a regional healthcare gateway and leader in life sciences. By integrating our strategic vision with Abbott's expertise, we aim to accelerate the development and deployment of innovative healthcare products and solutions, reducing time-to-market, improving healthcare outcomes, and ensuring that breakthrough therapies reach patients faster. This approach positions Abu Dhabi as a regional leader in fostering an agile, innovation-driven healthcare ecosystem that directly translates scientific advancements into tangible benefits for our community.' The strategic collaboration outlines a comprehensive plan focusing on four key pillars including localisation of Abbott's pharmaceutical portfolio, biosimilar development, digital transformation through electronic patient information leaflets, and a robust education and workforce development initiative. Mazen Bachir, Regional Director for Abbott's established pharmaceuticals business in the Gulf, Emerging Markets and Levant said: 'Abbott is proud to announce a strategic collaboration with the Department of Health – Abu Dhabi, aimed at advancing healthcare resilience and innovation in Abu Dhabi. Building on Abbott's long-standing commitment to the UAE's healthcare system, this partnership will focus on localising existing pharmaceutical products, and jointly exploring the development of biosimilars, supported by regulatory alignment. The collaboration also includes initiatives to digitise life science product information through electronic leaflets in alignment with the UAE's digital health strategy. Another key component of this collaboration is the development of education programs to build local capabilities. Additionally, Abbott and the Department of Health will evaluate opportunities for joint research and development to strengthen long-term healthcare sustainability in the UAE.' Led by DoH, a high-level delegation has embarked on a strategic mission to the United States from June 15 to 21, 2025. The delegation will conduct over 20 strategic meetings and visits with public and private sector leaders across the U.S., aimed at knowledge exchange, investment opportunities and the signing of new agreements that accelerate the adoption of advanced health solutions.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store